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Abstract 
The development of  mouse cerebral malaria (CM) upon Plasmodium berghei ANKA infection is 
under genetic control. Brain gene expression patterns were investigated in well-defined genetically 
CM-resistant (BALB/c and DBA/2) and CM-susceptible (C57BL/6 and CBA/J) mouse strains by 
using cDNA microarrays. By combining transcriptional profiling with rigorous statistical methods 
and cluster analysis, we identified a set of 69 genes that perfectly discriminated between mouse 
strains and between CM-resistant and CM-susceptible mice. The analysis of Gene Ontology terms 
revealed that the genes clustered and related to susceptibility to CM preferentially belonged to some 
biological process classes, such as those pertaining to immune responses. Using a false discovery 
rate of 5% and Welch t-test, we identified 31 genes with consistent differential expression between 
CM-resistant and CM-susceptible mice. These data indicate that microarray analysis may be useful 
to identify candidate genes potentially responsible for resistance or susceptibility to CM. 
 
 








Malarial disease is a major public health problem in the developing countries. Cerebral malaria (CM) 
is one of the most severe complications and a major cause of death [1,2]. A large body of evidence 
indicates that malaria infection and disease have heritable components, both in the human disease 
and in murine models. In the search for human genetic factors involved in malaria pathology or 
protection, several genes have been associated with resistance to severe malaria, and genes 
controlling parasitemia and mild malaria have been mapped [3-6]. The role of some genes has been 
demonstrated in mouse models and new malaria resistance genes that have been located on mouse 
genome remain to be identified [1,7]. 
To investigate the pathogenesis of CM, several animal models have been established, including mice 
infected by Plasmodium berghei ANKA (PbA) [7,8]. Although experimental CM models cannot 
reproduce all the features of human CM, several observations in mouse CM have been extended and 
confirmed in human disease. These include behavioural changes, histopathological features in brain 
and retina, biochemical changes in brain, blood-brain barrier function, immunological responses, and 
expression of molecules in brain and retina [1]. 
Inbred mouse strains markedly differ in their susceptibility to Plasmodium infection and disease.  In 
the murine model of PbA infection, BALB/c and DBA/2 mice are resistant to CM (CM-R) while 
C57BL/6 and CBA/J mice are susceptible to the neurological syndrome (CM-S). Our working 
hypothesis was that CM resistance/susceptibility differences may be due to genetic differences 
influencing gene expression. In particular, since CM is associated with an abnormal increase in the 
proinflammatory immune responses, it is conceivable that genes involved in inflammation are up-
regulated. 
Global expression analysis of 5053 genes was employed to identify differences in the brain 
expression between CM-R mice (BALB/c and DBA/2 mice) and CM-S mice (C57BL/6  and CBA/J). 
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We report here that CM-R mice and CM-S mice infected by PbA differ in their gene expression, the 
gene expression profile being discriminant of resistance or susceptibility to CM.  
 
Materials and Methods 
Mouse Strains and Phenotyping 
Six to 8 weeks old BALB/c, DBA/2 (CM-R strains), C57BL/6 and CBA/J (CM-S strains) female, 
were obtained from IFFA CREDO (Ch. River Lab, France) and kept in our facilities. Five from 
each strain were infected by i.p. injection of P. berghei ANKA. Parasitemia was monitored daily 
on blood smear. The CM-S mice developed a neurological syndrome which occurred 6 to 7 days 
after parasite inoculation with a cumulative mortality of 100 %. The CM-R mice die during the 
3rd or the 4th week of infection, with severe anaemia and hyperparasitemia [7]. 
Organ Sampling and Histology 
Brains were taken from CM-R and CM-S mice when the CM-S mice develop CM. Brains were 
completely removed and cut in two parts: one part was frozen in RNALater (Qiagen, TM) until 
RNA analysis, and the other one was embedded in Tissue Tek (Leica), snap frozen in liquid 
nitrogen and kept at -80°C until histopathological examination of cryosections. Histology 
consisted in specific antibody immunohistochemistry for VCAM-1 (Clone 429, BD Pharmingen) 
and ISCBP1 (C19, TEBU Bio). Afterwards, slides were photographed and protein expression 
was quantified using LUCIA software (Nikon) [8].  
RNA Isolation and cDNA Microarray Hybridizations 
Total RNA from brains was extracted using TRIzol reagent (Gibco-BRL, Life Technologies). 
The quality of RNA was confirmed on a formaldehyde agarose gel, and the concentration of 
RNA was determined by reading absorbance at 260/280 nm. Each mRNA sample extracted from 
an individual sample was run on a single microarray. All microarray procedures were done at our 
microarray core facility (http://tagc.univ-mrs.fr/).  cDNA microarrays were designed and 
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prepared as described [9]. The microarrays used in this study were composed of 5053 sequences. 
PCR amplification was performed as previously described [9], and PCR products were spotted 
onto nylon membranes (Hybond-N+, Amersham) with a GMS-417  arrayer (Affymetrix, Santa 
Clara, CA). About 20% of the genes included in this clone set are represented by two or more 
different cDNA clones, providing internal controls to assess the reproducibility of gene 
expression measurements. Microarrays were hybridized with 33P-labelled probes, first with an 
oligonucleotide sequence common to all spotted PCR products 
(5’TCACACAGGAAACAGCTATGAC-3’), then after stripping, with complex probes made 
from 5 µg of retrotranscribed total RNA. Probe preparations, hybridizations and washes were 
carried out as described previously [9]. After 48h hybridization, arrays were scanned with a FUJI 
BAS5000 machine at 25 µm resolution. 
Microarray Data Analysis 
Hybridization signals were quantified using ArrayGauge software (Fuji Ltd, Tokyo, Japan). All 
images were carefully inspected, and spots with overestimated intensities due to neighborhood 
effects were manually excluded. The data from 1 sample (CBA/J mouse) indicated a lower 
hybridization quality, so the sample was omitted from subsequent analyses. The data were 
filtered such that only spots with intensities that were two times greater than the median 
background in either microarray were used in the analysis, and the signal intensities were then 
corrected to take into account the amount of spotted DNA and the variability of experimental 
conditions, as described [10]. Of the 5053 spotted clones, we selected the clones that had 
detectable expression levels in at least 80% of the experiments (n=2145). Unsupervised 
hierarchical clustering investigated relationships between samples and relationships between 
genes. It was applied to data log-transformed and median-centred using the Cluster and 
TreeView programs (average linkage clustering using Pearson’s uncentered correlation as 
similarity metric) [11]. Using supervised SVM (Support Vector Machine) method, we 
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investigated the discrimination between CM-R and CM-S mice based on gene expression profiles 
[12]. 
Statistical analyses were performed using the TIGR MeV (MultiExperiment Viewer) v3.1 
software (http://www.tm4.org/mev.html). Figure 1 shows an outline of data analysis. A one-way 
ANOVA and SAM (Significant Analysis of Microarrays) procedures [13] were applied to look 
for strain- and CM-R/CM-S-specific variation in gene expression in the full data set. Welch t-
statistics was used to compare CM-R and CM-S mice [14]. Multiple test corrections were 
performed [15]. 
Gene annotation of all 2145 analysable genes/ESTs was obtained using EASE (Expression 
Analysis Systematic Explorer) software [16]. This program which allows a biological 
interpretation of gene clusters on the basis of GO terms was used to assess whether specific 
biological pathways were over-represented among the differentially expressed genes and within 
specific gene clusters. A score based on Fisher Exact test reports the probability that the 
prevalence of a particular theme within a cluster is due to chance alone given the prevalence of 
that theme in the population of all genes under study. 




To identify genes differentially expressed between CM-S and CM-R mice, we combined 
unsupervised and supervised clustering methods with several statistical approaches (figure 1). All 
the CBA/J mice (n=4) and C57BL/6 mice (n=5) developed CM while the BALB/c mice (n=5) 
and DBA/2 mice (n=5) did not, in spite of similar levels of parasitemia (10.4% ±6.4). The mRNA 
from the 19 different brain mouse samples was hybridized with cDNA arrays. The mRNA 
samples from each strain represented biological replicates. The degree of correlation between 
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gene expression levels of two samples from each strain was high (Pearson’s correlation 
coefficient R mean=0.89).  
To analyze the overall expression patterns, we used an unsupervised hierarchical clustering 
method that groups genes on the vertical axis and samples on the horizontal axis on the basis of 
similarity in their expression profiles (figure 2A). The similarities are summarized in a 
dendrogram, in which the pattern and length of the branches reflects the relatedness of the 
samples (figure 2B). On this basis, 8 of 10 CM-R mice and 9 of 9 CM-S mice were clustered 
together, respectively. The discrimination between CM-R and CM-S mice was highly significant 
(Fisher exact test : P<.0001). We assumed that 2 CM-R mice were incorrectly classified because 
of confounding genes, which were not differentially expressed between mouse groups.  
We, therefore, performed one-way ANOVA to look for strain- and CM-R/CM-S-specific 
variation in gene expression in the full data set (figure 1).  We generated empirical P values for 
each gene. Then, we selected all genes having P <.05, and we defined a set of 292 informative 
genes. We performed further unsupervised hierarchical clustering of samples based on the 
expression of the selected genes (figure 2C). As shown in figure 2D, this procedure successfully 
classified 10/10 CM-R mice and 9/9 CM-S mice. All mice of each strain were also correctly 
classified. 
To ascertain the accuracy of the prediction of CM molecular signature, we used a “one-out-
iterative cross-validation” testing procedure developed by the supervised SVM method. 
Iteratively, one of the 19 mouse samples was removed from the group, and was classified on the 
basis of the correlation between its expression profile and the median profile of samples from 
CM-R mice and CM-S mice. The prediction was considered correct if it corresponded to the 
actual group. Using this approach, we correctly classified 10 of 10 CM-R mice and 9 of 9 CM-S 




anuscript    inserm
-00276272, version 1
  8
To search for significant genes based on differential expression between mouse groups, we 
carried out more stringent statistical methods, which control the percentage of genes identified by 
chance. We applied two SAM procedures on the full data set to pick out mouse strain-specific 
and CM-R/CM-S-specific genes (figure 1). Differentially expressed genes were selected by using 
a false discovery rate (FDR) of 5%. Multi-class SAM yielded a list of 50 genes that showed a 
differential expression between mouse strains. Two-class SAM yielded a list of 40 genes that 
appeared to be differentially expressed between CM-R and CM-S mice. Twenty-one genes 
belonged to both lists, indicating that the effect of both strain and CM phenotype was detected. 
We, therefore, found 69 significant genes, which belong to the preliminary list of 292 informative 
genes. 
Unsupervised hierarchical clustering of samples based on the expression of the 69 significant 
genes successfully classified all the BALB/c, DBA/2, C57BL/6, and CBA/J mice on the one 
hand, and all the CM-R and CM-S mice on the other hand (figure 3). In the same way, 10 of 10 
CM-R mice and 9 of 9 CM-S mice were correctly classified by using supervised SVM method. 
We observed 7 clusters that were either strain-specific or CM-R/CM-S-specific. Clusters A and E 
grouped DBA/2 and CBA/J strains vs BALB/c and C57BL/6 strains. Clusters C and G 
discriminated C57BL/6 and BALB/c mice, respectively. Clusters B, D, and F separated CM-R 
and CM-S mice. 
We further analyzed the genes that we selected as CM-R/CM-S-specific by using the two-class 
SAM (figure 1). The 40 genes were assessed for bias due to strain-specific variation in gene 
expression. First, using Welch t-test, we searched for genes that were differentially expressed in 
brain samples from BALB/c and DBA/2 CM-R strains on the one hand, and C57BL/6 and CBA/J 
CM-S strains on the other hand. Then, we took into account these differences when we analyzed 
differential expression between CM-R and CM-S strains. 
Among the 40 genes selected as CM-R/CM-S-specific, we found 28 genes, the expression of 
which was not different between BALB/c and DBA/2 CM-R strains nor between C57BL/6 and 
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CBA/J CM-S strains (table 1). We showed by using Welch t-test and a FDR of 5% that the 
expression of 11 genes was lower in CM-S mice than in CM-R mice (figure 3, cluster F), and that 
the expression of 17 genes was higher in CM-S mice than in CM-R mice (figure 3, clusters B and 
D).  
Among the 40 genes selected as CM-R/CM-S-specific, we found 12 genes, the expression of 
which was different either between BALB/c and DBA/2 CM-R mice or between C57BL/6 and 
CBA/J CM-S mice (table 2). Using Welch t-test and a FDR of 5%, we found that the expression 
of Icsbp1 and Vcam1 was lower in CM-R strains than in C57BL/6 and CBA/J CM-S strains, and 
that the expression of Ccl27 was higher in CM-S strains than in BALB/c and DBA/2 CM-R 
strains. The expression of the other genes did not significantly differ between CM-R and CM-S 
(table 2). In all, we identified 31 genes associated with CM. 
The analysis of the GO terms of genes composing the different identified clusters by the EASE 
software showed an overrepresentation of genes involved in defence response (cluster D, 
P<.0004; cluster F, P<.008) and immune response (cluster D, P<.0002), compared to the 
population of all genes under study. For instance, the cluster D contains Samhd1, Serping1, 
Icsbp1, C1qb, Ifit3 and Ccl27, which are annotated with the “immune response” GO term.  
By using immunochemistry, we further analyzed the expression of two genes associated with 
susceptibility to CM. We chose Icsbp1, which is a crucial component of the IFNγ response, and 
Vcam1, which is a TNF-induced gene. The anti-ICSBP1 specific immunostaining, however, was 
not efficient enough to perform quantification. In contrast, the results were satisfactory for anti-
VCAM-1 antibody  (figure 4), and we found that Vcam1 was significantly overexpressed in CM-
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By combining transcriptional profiling with rigorous statistical methods and cluster analysis, we  
searched for differences in brain gene expression between CM-S (C57BL/6 and CBA/J) and CM-
R (BALB/c and DBA/2) mice. We used 5 biological replicates per group to take into account 
variability between mice. This allowed us to search for genes, which show small but significant 
changes in expression, and which may be biologically important. The approach used by others 
was rather to perform one or two microarrays for each condition or to pool the samples in order 
to minimize the experimental variability. Moreover, the selection of genes is generally based on 
non-statistically motivated criteria, such as « 2-fold-change » [17-19]. On the basis of a FDR of 
5%, we identified a set of 69 genes, the expression of which was significantly different between 
mouse strains and/or between CM-R and CM-S mice. The cluster analysis showed that this set of 
genes fully discriminated between mouse strains and between CM-R and CM-S mice. 
As several mouse malaria resistance loci have been mapped, we looked at the chromosomal 
localization of the selected genes. From the 69 selected genes, 67 had a reliable chromosomal 
location, the 2 missing data corresponding to 2 ESTs. Among the 67 genes, several were located 
at chromosomal regions previously shown to contain susceptibility loci for cerebral malaria 
caused by PbA. Usf1 and Pafah1b1 were located at the chromosome 1 region and the 
chromosome 11 region, which contain Berr1 and Berr2, respectively [20]. In addition, Nfatc1 and 
Egr1 were located at chromosome 18 that harbours the locus Esmr also controlling resistance to 
mouse CM [21]. We also found that Igf2r, Fkbp5, Lst1, and H2-D1 were located at the 
chromosome 17 region harbouring the Cmcs locus [22]. Interestingly, the same chromosome 17 
region was reported to contain genes controlling resistance to P. chabaudi (Char3) [23]. 
Moreover, three other chromosomal regions containing a locus controlling resistance to P. 
chabaudi, namely Char1 (chromosome 9), Char2 (chromosome 8) and Char4 (chromosome 3) 
contained Tcf12, Sntb2, Fnta, Icsbp1 and Vcam1, which we found differentially expressed 
between CM-R and CM-S mice [23]. It should be stressed that the chromosomal regions linked to 
malaria resistance are large. Therefore, microarray analyses should be helpful in identifying 
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candidate genes lying within those genetic regions and showing a differential expression between 
CM-R and CM-S mice. Cis-acting polymorphisms may affect both gene expression levels and 
CM resistance. 
We identified a cluster of genes up-regulated in C57BL/6 CM-S strain, compared to the CM-R 
strains and also the CBA CM-S strain. This is consistent with the data indicating that some CM 
mediators partly differ in CBA and C57BL/6 mice. In particular, it is thought that TNF may be a 
critical mediator of CM in CBA mice [24], while LTA may be a critical mediator of CM in 
C57BL/6 mice [25]. In the same way, we identified a cluster of genes specifically up-regulated in 
BALB/c CM-R mice, suggesting that some CM-R genetic factors may differ between BALB/c 
and DBA/2 CM-R mice. 
We identified three gene clusters associated with resistance or susceptibility to CM. Using Welch 
t-test and multiple test correction, we further confirmed that the expression of 31 genes 
significantly differ between CM-R and CM-S mice. This suggests that these genes and related 
physiological pathways may be critical in malaria pathogenesis in mice. To explore the possible 
functional role of these genes, we analyzed the occurrence of the GO terms within the clusters. 
The EASE analysis revealed that the genes clustered preferentially belonged to the two following 
biological process classes: defence response and immune response. Interestingly, the GO terms 
are organized in a hierarchical way [26], and the over-represented terms within the clusters of 
interest were related. Indeed, a number of known genes involved in the immune system and in the 
pro-inflammatory response had an expression associated with resistance or susceptibility to CM.  
In particular, Gzmb, Igf2r, Ctla2a, and C1qb were found to be up-regulated in CM-S mice. Gzmb 
(Ctla1) encodes granzyme B in cytotoxic T cells and Natural Killer cells [27,28], and induces 
apoptosis by caspase activation. Igf2r has been reported to bind Gzmb and to be essential for 
cytotoxic T cell-mediated apoptosis [29]. This is consistent with the data showing that perforin-
deficient C57BL/6 mice are resistant to CM. This indicates that the perforin/granzyme cytolytic 
pathway may be a major mechanism employed by CD8+ T cells during CM [30,31]. Ctla2a is 
H
AL author m
anuscript    inserm
-00276272, version 1
  12
expressed in mouse activated T cells [32]. C1qb that is the complement component 1 beta gene 
has also been shown to be up-regulated after permanent focal ischemia in the mouse [33]. In 
addition, overexpression of cyclooxygenase-2 (COX-2), which is expressed in mouse CM brain 
[34], leads to selective induction of C1qb expression in brain [35]. One might expect that the 
presence of locally produced complement components within brain is likely to induce a potent 
inflammatory response, and to contribute to brain damage. 
Pafhab1, which was down-regulated in CM-S mice, encodes a subunit Platelet Activating Factor 
acetylhydrolase, which regulates the level of platelet activating factor (PAF) in brain [36]. It has 
been suggested that PAF could play a pathophysiological role in severe malaria through 
activating platelets [37]. Platelets that are sequestered in cerebral microvessels are thought to be 
involved in endothelial cell damage and in malaria pathogenesis [1].  
We identified several genes known to be related to IFN or TNF responses. Samhd1, Ifit3 and Lst1 
are interferon-regulated genes [38-40], and Icsbp1, Stat1 are important components of the 
cellular response to IFNγ. Nfatc1 binds to Icsbp1 to promote the transcription of Il12B [41], and 
to Egr-1 to promote the transcription of Tnf and Il2 [42]. Vcam-1 and Ccl27 are TNF-induced 
genes [43,44], while Fkbp5 encodes a heat shock protein (Hsp) 90-binding immunophilin 
implicated in the TNF signal transduction pathway [45]. We found that Samhd1, Ifit3, Icsbp1, 
Stat1, Nfatc1, Fkbp5, and Vcam-1 expression level was nominally higher in the brain of CM-S 
mice than in the brain of CM-R mice. We analyzed the expression of Vcam-1 and Icsbp1 to 
validate the DNA microarray data by using immunochemistry method. We were unable to detect 
Icsbp1, indicating that the monoclonal antibody (mAb) did not perform well on cryosections. In 
contrast, Vcam-1 results confirmed the correlation between Vcam-1 expression level and 
susceptibility to CM. In the same way, Lou et al [46] showed that TNF induced a higher level of 
ICAM-1 and VCAM-1 expression in  CBA/J (CM-S) than in BALB/c (CM-R) brain 
microvascular endothelial cells (MVECs). In addition, Sexton et al [47] recently showed that 
interferon-regulated gene transcripts or IFN regulatory factors, such as Stat1, strongly increased 
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in brain from C57BL/6 (CM-S) mice infected by PbA. These results are in line with the current 
knowledge of the physiological pathways involved in malaria pathogenesis. The role of IFNγ, 
TNF and their receptors in mouse CM has been demonstrated by using neutralizing mAb [48] or 
gene targeting [49-51]. Moreover, human TNF and IFNγR1 polymorphisms are associated with 
susceptibility to CM [52,53]. High levels of TNF and IFNγ have been measured in patients with 
severe malaria [48,54], and TNFR2 complex has been observed on the surface of MVECs in 
human CM [1] . NK cells, CD4+ T cells and γδ T cells were shown to produce IFNγ in in vitro 
models of P. falciparum infection [55-57]. In mice, NK T cells or NK cells could be important 
sources of IFNγ, since the introduction of C57BL/6 (CM-S) strain NKC genes into a BALB/c 
(CM-R) strain results in an increased production of IFNγ, an increased Th1 response, and 
susceptibility to CM [58].  
Here, we show that there are gene expression profiles associated with susceptibility to mouse 
CM. We identified several genes, the expression of which significantly differs between CM-S 
and CM-R mice. The concordance between our data and those from literature with respect to the 
function of genes strengthens the validity of our results. This suggests that these genes -or genes 
involved in the same physiological pathway- are implicated in malaria pathogenesis in mice and 
can be considered as candidate genes in humans. Microarray analyses should provide new 
insights into the knowledge of key genes governing the response to malaria.  
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A schematic outline of step-wise data analysis. SAM, Significant Analysis of Microarrays. 
FDR, False Discovery Rate. HCL, Hierarchical Clustering. SVM, Support Vector Machine. CM, 
cerebral malaria. CM-R, CM-resistant mice. CM-S, CM-susceptible mice. A one-way ANOVA 
was applied to look for strain- and CM-R/CM-S-specific variation in gene expression in the full 
data set. Empirical P-values were computed for each gene by bootstrapping from 10,000 
permutations. All genes having P<.05 were selected for unsupervised and supervised clusterings. 
To estimate the accuracy of prediction of the “CM molecular signature”, we applied the “one-
out-iterative cross-validation” testing procedure developed by the supervised SVM method. 
Briefly, the algorithm withholds one of the 19 mice samples, builds a training set based only on 
the remaining samples, and predicts the class of the withheld sample. The process was repeated 
for each sample, and a Fisher exact test was used to assess the significance of the classification. 
From the full data set, significant differential gene expression was determined using SAM 
method. The SAM algorithm gives an estimate of the FDR, which is the proportion of false 
positives among all of the genes initially identified as being differentially expressed. The multi-
class and two-class unpaired SAM procedures were used to identify mouse strain-specific and 
CM-R/CM-S-specific genes, respectively, on the basis of 10,000 bootstrapped permutations. 
Missing values were imputed using a K-nearest-neighbor algorithm. Multiple testing problem 
was addressed by choosing a FDR of 5%. The significant genes with differential expression 
between CM-R and CM-S mice were extracted from the SAM results with Welch t-test for small 
samples with unequal variances in the two groups. Empirical P-values were computed for each 
gene from 10,000 bootstrapped permutations. All genes having P<.05 were selected and we 









Gene expression profiles in CM-R mice and CM-S mice. A, Hierarchical clustering of 19 brain 
tissue samples representing the four mouse strains (BALB/c, DBA/2, C57BL/6, CBA/J) and 2145 
cDNA clones (full data set) based on mRNA expression levels. Each row represents a gene and 
each column represents a sample. The normalized expression value for each gene was depicted 
according to the colour scale at the bottom. Red and green indicate expression levels above and 
below the median, respectively. Grey indicates missing data. Dendograms of samples (above 
matrix) and genes (to the left of matrix) represent overall similarities in gene expression profiles. 
B, Dendogram of samples representing the results of the same global hierarchical clustering 
applied to the 19 brain tissue samples. Two groups of samples were defined: CM-R mice 
(BALB/c, DBA/2) in blue and CM-S mice (C57BL/6, CBA/J) in red. C, Hierarchical clustering 
of the 19 brain tissue samples using expression levels of 292 informative genes differentially 
expressed between the four mouse strains. This group of informative genes was extracted from 
the full data set (n=2145) by an one-way ANOVA test on the basis of 10,000 permutations 
(P<.05). D, Dendogram of the samples representing the results of the same hierarchical clustering 
applied to the 292 informative genes. 
 
Figure 3. 
Hierarchical classification of strain-specific and CM-R and CM-S significant genes. 
Hierarchical clustering of the 19 brain tissue samples using expression levels of 69 significant 
genes differentially expressed between the four mouse strains (BALB/c, DBA/2, C57BL/6, 
CBA/J). This group of significant genes was extracted from the full data set (n=2145) by a SAM 
procedure on the basis of 10,000 permutations, and a FDR of 5%. The Clone ID and the UniGene 









VCAM-1 expression in brain vessels of CM-S and CM-R mice. A, Histological pictures of 
CM-S and B, CM-R mice. VCAM-1 expression was expressed for each vessel as a ratio of the red 
chromogen area out of the total vessel lumen. C, VCAM-1 was significantly overexpressed in 
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Name CloneID MGI ID Scorea
Empirical P 
value
BC008163 (B) CDNA sequence BC008163 1263080 2385211 3.67 .0018
Myohd1 (B) Myosin head domain containing 1 1263076 1913446 3.72 .0017
Ckap1 (B) Cytoskeleton-associated protein 1 1226488 1913661 3.51 .0009
Samhd1 (D) SAM domain and HD domain. 1 1243829 1927468 3.60 .0042
Cebpd (D) Transcribed locus // CCAAT/enhancer binding protein (C/EBP). delta 1344658 103573 3.40 .0039
Igf2r (D) Insulin-like growth factor 2 receptor 1226545 96435 3.73 .0029
Ctla2a (D) Cytotoxic T lymphocyte-associated protein 2 alpha 749331 88554 3.89 .0013
1810034K20Rik (D) RIKEN cDNA 1810034K20 gene 1226407 1915131 4.72 <.00001
Ests (D) - 621261 - 3.79 .0009
Epc2 (D) Enhancer of polycomb homolog 2 (Drosophila) 617260 1278321 4.04 .0007
Bub3 (D) Budding uninhibited by benzimidazoles 3 homolog (S. cerevisiae) 1226577 1343463 3.31 .0016
Dnajb4 (D) DnaJ (Hsp40) homolog. subfamily B. member 4 1225671 1914285 3.68 .0016
C1qb (D) Complement component 1. q subcomponent. beta polypeptide 1225655 88224 3.74 .0006
Fkbp5 (D) FK506 binding protein 5 1243723 104670 4.69 .0006
Ifit3 (D) Interferon-induced protein with tetratricopeptide repeats 3 598493 1101055 4.46 .0002
Gzmb (D) Granzyme B 1378751 109267 4.44 .0009
Nfatc1 (D) Nuclear factor of activated T-cells. cytoplasmic. calcineurin-dependent 1 575679 102469 4.37 .0013
Dusp11 (F) Dual specificity phosphatase 11 (RNA/RNP complex 1-interacting) 1226939 1919352 -4.87 .0001
Lst1 (F) Leukocyte specific transcript 1 621304 1096324 -4.37 .0008
Igh-6 (F) Immunoglobulin heavy chain 6 (heavy chain of IgM) 1263881 96448 -4.03 .0011
H2-D1 (F) Histocompatibility 2. D region locus 1 576114 95896 -3.83 .0013
Ccrn4l (F) CCR4 carbon catabolite repression 4-like (S. cerevisiae) 1263979 109382 -3.54 .0004
Pafah1b1 (F) Platelet-activating factor acetylhydrolase. isoform 1b. beta1 subunit 1263702 109520 -4.79 <.00001
Slc25a19 (F) 
Solute carrier family 25 (mitochondrial deoxynucleotide carrier). member 
19 
1263222 1914533 -4.66 .0004
9630015D15Rik (F) RIKEN cDNA 9630015D15 gene 1244014 2140359 -3.67 .0036
Pcnxl3 (F) Pecanex-like 3 (Drosophila) 1263238 1861733 -4.18 .0013
Gcn1l1 (F) GCN1 general control of amino-acid synthesis 1-like 1 (yeast) 1226847 2444248 -4.60 .0004
Fnta (F) Farnesyltransferase. CAAX box. alpha 1263688 104683 -3.92 .0007
 
NOTE. The genes are listed following the clustering order in figure 2. CM-R, CM-resistant mice. CM-S, CM-susceptible mice. 
a  Positive score: CM-S mice gene expression was higher than CM-R mice gene expression. 
   Negative Score: CM-R mice gene expression was higher than CM-S mice gene expression.  
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Table 2. Cerebral malaria (CM) specific genes with a strain effect obtained from Welch t-test and 
FDR 5%. 
Groupa, Gene symbol 
(Cluster) 
Name CloneID MGI ID Welch t-test Scoreb 
Empirical 
P valuec 
Group A       
CM-R vs C57BL/6 8.18 <.00001*    Ccl21a (C) Chemokine (C-C motif) ligand 21a 
(leucine) 
576610 1349182 
CM-R vs CBA/J 2.43 … 
CM-R vs C57BL/6 6.73 .00033*    Tle4 (C) Transducin-like enhancer of split 4, 
homolog of Drosophila E(spl) 
576586 104633 
CM-R vs CBA/J 2.02 … 
CM-R vs C57BL/6 2.47 .033*    Icsbp1 (D) Interferon consensus binding 
protein 1 
577563 96395 
CM-R vs CBA/J 6.36 <.00001* 
CM-R vs C57BL/6 6.58 <.00001*    1110008H02Rik (D) RIKEN cDNA 1110008H02 gene 1226403 1921074 
CM-R vs CBA/J 2.31 ... 
CM-R vs C57BL/6 6.29 <.00001*    Vcam1 (D) Vascular cell adhesion molecule 1 576563 98926 
CM-R vs CBA/J 2.92 .016* 
Group B       
BALB/c vs CM-S 6.31 <.00001*    Ccl27 (D) Chemokine (C-C motif) ligand 27 1446118 1343459 
DBA/2 vs CM-S 2.40 .032* 
BALB/c vs CM-S -5.73 .0005*    Arc (G) Activity regulated cytoskeletal-
associated protein 
3327010 88067 
DBA/2 vs CM-S -2.50         .037 
Group C       
BALB/c vs C57BL/6 10.30 <.00001* 
BALB/c vs CBA/J 2.22 … 
DBA/2 vs C57BL/6 4.28 <.00001* 
   C630013N10Rik (C) RIKEN cDNA C630013N10 gene 1225973 2443079 
DBA/2 vs CBA/J 0.41 … 
BALB/c vs C57BL/6 11.74 <.00001* 
BALB/c vs CBA/J 3.84 <.00001* 
DBA/2 vs C57BL/6 5.34 <.00001* 
   Ccl21b (C) Chemokine (C-C motif) ligand 21b 
(serine) 
1379475 1349183 
DBA/2 vs CBA/J 0.73 … 
BALB/c vs C57BL/6 15.05 <.00001* 
BALB/c vs CBA/J 2.66 .031* 
DBA/2 vs C57BL/6 10.32 <.00001* 
   Pttg1 (C) Pituitary tumor-transforming 1 1243983d 
(1226978) 
1353578 
DBA/2 vs CBA/J 0.77 … 
BALB/c vs C57BL/6 -4.53 <.00001* 
BALB/c vs CBA/J -1.63 … 
DBA/2 vs C57BL/6 -4.81 <.00001* 
   2610005L07Rik (F) RIKEN cDNA 2610005L07 gene 1262936 1914283 
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NOTE. The genes, the expression of which significantly differed between CM-R and CM-S mice, are shown in bold. A false 
discovery rate (FDR) of 5% was used. 
a Group A: the expression of the gene differed between C57BL/6 and CBA/J mice.  
  Group B: the expression of the gene differed between BALB/c and DBA/2 mice.  
  Group C: the expression of the gene differed between C57BL/6 and CBA/J mice, and between BALB/c and DBA/2 mice. 
b Positive score: CM-S mice gene expression was higher than CM-R mice gene expression. 
  Negative Score: CM-R mice gene expression was higher than CM-S mice gene expression.  
c Significant results with a FDR of 5% are indicated by an asterisk. 
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